Neck Cancer Clinical Trial
— DERMISHEADOfficial title:
Low-level Laser Therapy as a Tool for the Prevention of Radiodermatitis in Head and Neck Cancer Patients
Verified date | August 2021 |
Source | Hasselt University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Up to 90% of the radiotherapy patients will develop a certain degree of skin reaction at the treated area, also known as radiodermatitis (RD). Currently, there is a wide variety of strategies to manage RD, including creams, gels, ointments, wound dressings. However, up to now, there is still no comprehensive, evidence-based consensus for the treatment of RD. Low-level laser therapy (LLLT) is a promising, non-invasive technique for treating RD. In a recent study conducted in our research group, LLLT prevented the aggravation of RD and provided symptomatic relief in patients undergoing radiotherapy for breast cancer after breast-sparing surgery. This was the first prospective study investigating the potential of LLLT for RD. In the current study, we want to investigate the efficacy of LLLT as a tool for the prevention of radiodermatitis in head and neck cancer patients.
Status | Completed |
Enrollment | 46 |
Est. completion date | February 2020 |
Est. primary completion date | February 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Diagnosis of head and neck squamous cell carcinomas (HNSCC) starting in the lip, salivary gland, oral cavity (mouth), nasal cavity (inside the nose), paranasal sinuses, pharynx, or larynx - Scheduled for radiotherapy (>60 Gy), chemo-irradiation or bio-radiation either as primary or as post-operative treatment to the head and neck region - Age = 18 years - Able to comply to the study protocol - Able to sign written informed consent - Signed written informed consent Exclusion Criteria: - Previous irradiation to the head and/or neck region - Metastatic disease - Patients with pre-existing skin rash, ulceration or open wound in the treatment area - Patients with known allergic and other systemic skin diseases even when not directly affecting irradiated fields - Substance abuse patients or patients with medical, psychological or social conditions that may interfere with the patient's participation in the study or evaluation of the study results as judged by the investigator - Any condition that is unstable or could affect the safety of the patient and their compliance in the study as judged by the investigator - Patients using high doses of non-steroidal anti-inflammatory drugs |
Country | Name | City | State |
---|---|---|---|
Belgium | Ziekenhuis Oost-Limburg | Genk | |
Belgium | Jessa Ziekenhuis | Hasselt |
Lead Sponsor | Collaborator |
---|---|
Hasselt University | Jessa Hospital |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Radiation Dermatitis Grade | objective scoring of the severity of radiation dermatitis using the grading system of the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer (RTOG/EORTC) | 3 months (during radiation therapy and one month after) | |
Primary | Radiation Dermatitis Assessment | radiation dermatitis assessment scale (Radiation-Induced Skin Reaction Assessment Scale, RISRAS) | 3 months (during radiation therapy and one month after) | |
Primary | Objective measurement of trans epidermal water loss of the skin | Tewameter TM 300 will be used to objectively assess the skin barrier function by measuring the trans epidermal water loss of the skin | 3 months (during radiation therapy and one month after) | |
Primary | Objective measurement of the skin hydration | Corneometer CM825 will be used to objectively assess the skin barrier function by measuring the skin hydration | 3 months (during radiation therapy and one month after) | |
Primary | Objective measurement of degree of erythema of the skin | Mexameter MX18 will be used to objectively measure the degree of erythema of the skin | 3 months (during radiation therapy and one month after) | |
Primary | Analyze the skin cytokine content of the irradiated and non-irradiated breast | Collect skin tape samples of the irradiated and non-irradiated breast in order to analyze these samples on cytokines by ELISA | 3 months (during radiation therapy and one month after) | |
Secondary | VAS-score | Evaluation of pain using a visual analogue scale (VAS) | 3 months (during radiation therapy and one month after) | |
Secondary | Skin dex 16 | Health-related quality of life measure specific to skin diseases (Skindex-16) | 3 months (during radiation therapy and one month after) | |
Secondary | Satisfaction with therapy | Self-report on the efficacy of and the global satisfaction with the management of radiodermatitis | 3 months (during radiation therapy and one month after) | |
Secondary | moist desquamation | Onset time of moist desquamation | 3 months (during radiation therapy and one month after) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05746780 -
Bilateral Elective Neck Dissection in Salvage Total Laryngectomy
|
||
Recruiting |
NCT04708470 -
A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers
|
Phase 1/Phase 2 | |
Completed |
NCT00318890 -
Cisplatin and Docetaxel Plus Docetaxel and Radiotherapy With Amifostine for Squamous Cell Carcinoma of the Head and Neck
|
Phase 1/Phase 2 | |
Completed |
NCT00798655 -
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
|
Phase 2 | |
Completed |
NCT06010381 -
Muscle Energy Technique Versus Maitland Mobilization on Shoulder Pain and Disability
|
N/A | |
Recruiting |
NCT06432998 -
Perineal Massage in Women With Gynecological Cancer
|
N/A | |
Completed |
NCT02714920 -
DNA Repair Enzyme Signature in Head and Neck Cancer (CHEMRAD)
|
N/A | |
Terminated |
NCT01910753 -
Physical Activity Program and Nutrition Therapeutic Education During Treatment of Head and Neck Cancer Population
|
N/A | |
Completed |
NCT01194466 -
Transcutaneous Electrical Nerve Stimulation (TENS) and Head and Neck Cancer Pain (HNC) (TENS & HNC)
|
N/A | |
Recruiting |
NCT03530033 -
Lidocaine Reduces Muscle Tremor is Beneficial for Intraoperative Recurrent Laryngeal Nerve Monitoring
|
N/A | |
Recruiting |
NCT05549414 -
Pivotal Study of Proton Radiotherapy Treatments Using Fixed Beam Chair-Based Delivery System
|
N/A | |
Recruiting |
NCT04750434 -
PET MRI as a Staging Tool for Head and Neck Cancer
|
||
Withdrawn |
NCT05472506 -
Oral AHR Antagonist in Combination With Nivolumab in Patients With PD-1 Resistant Metastatic or Recurrent Head and Neck Cancer
|
Phase 1 | |
Not yet recruiting |
NCT04261179 -
Study Comparing Lymphoseek® vs. Albumin Nanocolloid in Head and Neck, Melanoma and Breast Cancer
|
Phase 4 | |
Completed |
NCT00723463 -
Determine if Apparent Diffusion Coefficient (ADC) Values Can Differentiate Tumors From Normal Tissue
|
Phase 0 | |
Recruiting |
NCT04673981 -
Neurosensorial Disorder and Pain in Oral Cavity and Oropharynx Cancer Traited Patients (OCAPA)
|
N/A | |
Not yet recruiting |
NCT05946577 -
Association Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study
|
||
Completed |
NCT05246891 -
Rehabilitation Nursing Program in Otolaryngology
|
||
Recruiting |
NCT04722523 -
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
|
Phase 1 | |
Completed |
NCT03245788 -
Effectiveness of Lay Navigators in Meeting Cancer Patients' Non-Clinical Needs: A Pilot Study
|
N/A |